Medication (de)prescribing in hospitalized geriatric patients with sarcopenia, less is more?
- Conditions
- 1001795910047075stoppen/ starten/ dosisaanpassing van medicatie bij acuut zieke sarcopene geriatrische patienten met polyfarmacy en diverse uitgebreide co-morbiditeit waarbij de betrokken aandoeningen heel divers kunnen zijn en de reden van de medicatie wijziging ook verschillend kan zijn.medication adjustment in older frail hospitalized patients with low muscle strength and muscle mass using at least 5 different medications. (de)prescribing in acutely ill hospitalized sarcopenic geriatric patients with polypharmacy.
- Registration Number
- NL-OMON53702
- Lead Sponsor
- Zuyderland Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 160
frail older adults, 70 Y and older with sarcopenia and polypharmacy admitted to
the acute care hospital ward because of an acute medical problem
If a patient is not instructable. If a patient has an implantable cardioverter
defibrillator (ICD) or no informed consent or if there is no (legal)
representative with informed consent if the patient is (temporary)
incapacitated.
Patients in a palliative phase will be excluded from this study, since most
medication will be stopped in a palliative setting.
Finally, patients with an expected admission time of less than 48 hours will be
excluded due to logistic reasons (48 hours are needed to screen for
suitability, minimum of 24 hours to consider participation).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>number and type of medication stopped during medication review and not<br /><br>restarted within 1, 3 and 6 months</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary endpoints: number and severity of Adverse Drug Reactions (ADR) and<br /><br>complications due to medication (e.g. delirium or falls), hospital readmission,<br /><br>quality of life (QoL) and mortality</p><br>